Spero Therapeutics Long Term Deferred Assets (Quarterly) Trends

Spero Therapeutics, Inc. (SPRO)

2.30 -0.10 (-4.17%) USD | NASDAQ | Feb 20, 16:00

2.295 0.00 (0.00%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for SPRO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

BioMarin Pharmaceutical, Inc.	Upgrade
Amicus Therapeutics, Inc.	--
Cassava Sciences, Inc.	--
Alpha Teknova, Inc.	--
Pyxis Oncology, Inc.	--